Cited by 1,793Tuberous Sclerosis Complex ResearchGenetic and rare skin diseases.PI3K/AKT/mTOR signaling in cancer

The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.

The Tuberous Sclerosis Complex

Crino, Peter B., Nathanson, Katherine L., Henske, Elizabeth Petri·2006·New England Journal of Medicine

Open this paper in CoChat — free account

Abstract

The tuberous sclerosis complex (TSC), a multisystem, autosomal dominant disorder affecting children and adults, results from mutations in one of two genes, TSC1 (encoding hamartin) or TSC2 (encoding tuberin). In this article, the current knowledge of the pathogenesis of the disease and its management are discussed.

Integrity signals

Registry

Crossref · 10.1056/nejmra055323

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Phosphatidylinositol 3-Kinase/Akt Pathway Regulates Tuberous Sclerosis Tumor Suppressor Complex by Phosphorylation of Tuberin
Dan, H. C., Sun, M., Yang, L., Feldman, R. I., Sui, X.-M., Ou, C. C., Nellist, M. D., Yeung, R. S. W., Halley, D. J. J., Nicosia, S. V., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205838200 · Cited by 370
Retracted
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911
Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34
Slegtenhorst, M. V., Hoogt, R. D., Hermans, C., Nellist, M., Janssen, B., Verhoef, S., Lindhout, D., Ouweland, A. V. D., Halley, D., Young, J., et al. (1997) · Science · doi:10.1126/science.277.5327.805 · Cited by 1,648
Self-citation
Identification and characterization of the tuberous sclerosis gene on chromosome 16
(1993) · Cell · doi:10.1016/0092-8674(93)90618-z · Cited by 1,645
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555
Phosphorylation and Functional Inactivation of TSC2 by Erk
Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P., & Pandolfi, P. P. (2005) · Cell · doi:10.1016/j.cell.2005.02.031 · Cited by 1,268
Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression
Fingar, D. C., & Blenis, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207542 · Cited by 1,264
The LKB1 tumor suppressor negatively regulates mTOR signaling
Shaw, R. J., Bardeesy, N. M., Manning, B. D., Lopez, L. V., Kosmatka, M., DePinho, R. A., & Cantley, L. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.007 · Cited by 1,107

Show all 98 references

Research works printed but not linked: 7

Bourneville DM, 1880, Arch Neurol (Paris), 1, 81
Bjornsson J, 1996, Am J Pathol, 149, 1201
Henske EP, 1996, Am J Hum Genet, 59, 400
Plank TL, 1998, Cancer Res, 58, 4766
Plank TL, 1999, Mod Pathol, 12, 539
Wienecke R, 1996, Oncogene, 13, 913
Liu MY, 2002, Cancer Res, 62, 6475

Sorted by citations

Items 401–500 of 1,001

AMP-Activated Protein Kinase Signaling Results in Cytoplasmic Sequestration of p27
Short, J. D., Houston, K. D., Dere, R., Cai, S.-L., Kim, J., Johnson, C. L., Broaddus, R. R., Shen, J., Miyamoto, S., Tamanoi, F., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5756 · Cited by 59
Recent Advances and Challenges of mTOR Inhibitors Use in the Treatment of Patients with Tuberous Sclerosis Complex
Palavra, F., Robalo, C., & Reis, F. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9820181 · Cited by 56
Efficacy of Sirolimus in Treating Tuberous Sclerosis and Lymphangioleiomyomatosis
Paul, E., & Thiele, E. A. (2008) · New England Journal of Medicine · doi:10.1056/nejme0707153 · Cited by 56
Epilepsy surgery and tuberous sclerosis complex: special considerations
Bollo, R. J., Kalhorn, S. P., Carlson, C., Haegeli, V., Devinsky, O., & Weiner, H. L. (2008) · Neurosurgical FOCUS · doi:10.3171/foc/2008/25/9/e13 · Cited by 56
Mammalian target of rapamycin (mTOR) activation in focal cortical dysplasia and related focal cortical malformations
Wong, M. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.10.002 · Cited by 56
Enhanced GABAergic network and receptor function in pediatric cortical dysplasia Type IIB compared with Tuberous Sclerosis Complex
Cepeda, C., André, V., Hauptman, J. S., Yamazaki, I., Huynh, M. N., Chang, J. W., Chen, J., Fisher, R. S., Vinters, H. V., Levine, M. S., et al. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.08.015 · Cited by 57
Is mTOR inhibition a systemic treatment for tuberous sclerosis?
Moavero, R., Coniglio, A., Garaci, F., & Curatolo, P. (2013) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/1824-7288-39-57 · Cited by 55
PTEN hamartoma tumor syndrome
Mester, J. L., & Eng, C. (2015) · Handbook of clinical neurology · doi:10.1016/b978-0-444-62702-5.00009-3 · Cited by 55
Megalencephaly and Macrocephaly
Winden, K. D., Yuskaitis, C. J., & Poduri, A. (2015) · Seminars in Neurology · doi:10.1055/s-0035-1552622 · Cited by 55
65 YEARS OF THE DOUBLE HELIX: One gene, many endocrine and metabolic syndromes: PTEN-opathies and precision medicine
Yehia, L., & Eng, C. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0162 · Cited by 58
The Association Between Autism and Errors in Early Embryogenesis: What Is the Causal Mechanism?
Ploeger, A., Raijmakers, M. E. J., van der Maas, H. L. J., & Galis, F. F. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.10.010 · Cited by 57
TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity
Liang, M.-C., Ma, J., Chen, L., Kozłowski, P., Qin, W., Li, D. D., Goto, J., Shimamura, T., Hayes, D. N., Meyerson, M. M., et al. (2009) · Oncogene · doi:10.1038/onc.2009.452 · Cited by 54
Distinctive Morphology of Renal Cell Carcinomas in Tuberous Sclerosis
Schreiner, A. M., Daneshmand, S., Bayne, A. P., Countryman, G., Corless, C. L., & Troxell, M. L. (2009) · International Journal of Surgical Pathology · doi:10.1177/1066896909333510 · Cited by 54
Differential expression of major histocompatibility complex class I in developmental glioneuronal lesions
Prabowo, A. S., Iyer, A. M., Anink, J. J., Spliet, W. G. M., van Rijen, P. C., & Aronica, E. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-12 · Cited by 54
Is Epilepsy a Preventable Disorder? New Evidence from Animal Models
Giblin, K. A., & Blumenfeld, H. (2010) · The Neuroscientist · doi:10.1177/1073858409354385 · Cited by 56
Expression of the Interleukin 6 System in Cortical Lesions From Patients With Tuberous Sclerosis Complex and Focal Cortical Dysplasia Type IIb
Shu, H., Zhang, C., Yin, Q., An, N., Liu, S., & Yang, H. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181eaeae5 · Cited by 54
Disruption of TBC1D7, a subunit of the TSC1-TSC2 protein complex, in intellectual disability and megalencephaly
Capo‐Chichi, J., Tcherkezian, J., Hamdan, F. F., Décarie, J. C., Dobrzeniecka, S., Patry, L., Nadon, M.-A., Mucha, B. E., Major, P., Shevell, M. I., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101680 · Cited by 54
The role of glia in epilepsy, intellectual disability, and other neurodevelopmental disorders in tuberous sclerosis complex
Wong, M. (2019) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-019-9289-6 · Cited by 55
Lessons from the skin—cutaneous features of familial cancer
Winship, I., & Dudding, T. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70126-8 · Cited by 54
Risk of Cancer in Children, Adolescents, and Young Adults with Autistic Disorder
Chiang, H., Liu, C., Hu, Y., Chen, S., Hu, L., Shen, C.-C., Yeh, C., Chen, T., & Gau, S. S. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.10.029 · Cited by 55
Stroke and Hypertension in Children and Adolescents
Kupferman, J. C., Zafeiriou, D., Lande, M. B., Kirkham, F. J., & Pavlakis, S. G. (2016) · Journal of Child Neurology · doi:10.1177/0883073816685240 · Cited by 53
Everolimus dosing recommendations for tuberous sclerosis complex– associated refractory seizures
Franz, D. N., Lawson, J. A., Yapıcı, Z., Brandt, C., Kohrman, M. H., Wong, M., Milh, M., Wiemer‐Kruel, A., Voi, M., Coello, N., et al. (2018) · Epilepsia · doi:10.1111/epi.14085 · Cited by 53
Mammalian Target of Rapamycin Signaling and Autophagy: Roles in Lymphangioleiomyomatosis Therapy
Yu, J. J., Parkhitko, A. A., & Henske, E. P. (2010) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200909-104js · Cited by 51
Self-citation
Regression of subependymal giant cell astrocytomas with RAD001 (Everolimus) in tuberous sclerosis complex
Yalon, M., Ben‐Sira, L., Constantini, S., & Toren, A. (2010) · Child s Nervous System · doi:10.1007/s00381-010-1222-y · Cited by 50
Genomic analysis of the molecular neuropathology of tuberous sclerosis using a human stem cell model
Grabole, N., Zhang, J. D., Aigner, S., Ruderisch, N., Costa, V., Weber, F. C., Theron, M., Berntenis, N., Spleiss, O., Ebeling, M., et al. (2016) · Genome Medicine · doi:10.1186/s13073-016-0347-3 · Cited by 51
Sensitive period for rescuing parvalbumin interneurons connectivity and social behavior deficits caused by TSC1 loss
Amegandjin, C. A., Choudhury, M., Jadhav, V., Carriço, J. N., Quintal, A., Berryer, M. H., Snapyan, M., Chattopadhyaya, B., Saghatelyan, A., & Cristo, G. D. (2021) · Nature Communications · doi:10.1038/s41467-021-23939-7 · Cited by 53
Newborn cortical neurons: only for neonates?
Feliciano, D. M., & Bordey, A. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2012.09.004 · Cited by 51
Targeted therapeutic strategies for the management of renal cell carcinoma
Singer, E. A., Gupta, G. N., & Srinivasan, R. (2012) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328351c646 · Cited by 51
Acyl-CoA synthetase-4, a new regulator of mTOR and a potential therapeutic target for enhanced estrogen receptor function in receptor-positive and -negative breast cancer
Orlando, U. D., Castillo, A. F., Dattilo, M. A., Solano, A. R., Maloberti, P. M., & Podesta, E. J. (2015) · Oncotarget · doi:10.18632/oncotarget.5822 · Cited by 51
Rheb Activation in Subventricular Zone Progenitors Leads to Heterotopia, Ectopic Neuronal Differentiation, and Rapamycin-Sensitive Olfactory Micronodules and Dendrite Hypertrophy of Newborn Neurons
Lafourcade, C., Lin, T. V., Feliciano, D. M., Zhang, L., Hsieh, L. S., & Bordey, A. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1840-12.2013 · Cited by 51
Intrafamilial Phenotypic Variability in Tuberous Sclerosis Complex
Lyczkowski, D. A., Conant, K. D., Pulsifer, M. B., Jarrett, D. Y., Grant, P. E., Kwiatkowski, D. J., & Thiele, E. A. (2007) · Journal of Child Neurology · doi:10.1177/0883073807307093 · Cited by 51
mTOR signaling in neural stem cells: from basic biology to disease
Magri, L., & Galli, R. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1196-x · Cited by 52
mTOR Inhibition: From Aging to Autism and Beyond
Kaeberlein, M. R. (2013) · Scientifica · doi:10.1155/2013/849186 · Cited by 52
Tuberous sclerosis and epilepsy: Role of astrocytes
Wong, M., & Crino, P. B. (2012) · Glia · doi:10.1002/glia.22326 · Cited by 49
Self-citation
Inhibition and Termination of Physiological Responses by GTPase Activating Proteins
Ligeti, E., Welti, S., & Scheffzek, K. (2012) · Physiological Reviews · doi:10.1152/physrev.00045.2010 · Cited by 61
Timing of mTOR activation affects tuberous sclerosis complex neuropathology in mouse models
Magri, L., Cominelli, M., Cambiaghi, M., Cursi, M., Leocani, L., Minicucci, F., Poliani, P. L., & Galli, R. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.012096 · Cited by 51
Self-injury and aggression in tuberous sclerosis complex: cross syndrome comparison and associated risk markers
Eden, K., de Vries, P. J., Moss, J. F., Richards, C., & Oliver, C. (2014) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-6-10 · Cited by 51
Malignant perivascular epithelioid cell tumor in the female genital tract
Liu, C., Chao, W., Lin, S., Lau, H., Wu, H.-H., & Wang, P. (2019) · Medicine · doi:10.1097/md.0000000000014072 · Cited by 51
Advances in the treatment of tuberous sclerosis complex
Leclezio, L., & de Vries, P. J. (2015) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000136 · Cited by 51
Poliosis circumscripta: Overview and underlying causes
Sleiman, R., Kurban, M., Succaria, F., & Abbas, O. M. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.05.022 · Cited by 50
Everolimus for the Treatment of Tuberous Sclerosis Complex–Related Cardiac Rhabdomyomas in Pediatric Patients
Dahdah, N. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.06.076 · Cited by 50
Racial Disparities and Preventive Measures to Renal Cell Carcinoma
Sims, J. N., Yedjou, C. G., Abugri, D. A., Payton, M., Turner, T., Miele, L., & Tchounwou, P. B. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15061089 · Cited by 50
Tuberous Sclerosis Complex: State-of-the-Art Review with a Focus on Pulmonary Involvement
von Ranke, F. M., Zanetti, G. M. R., Silva, J. L. P. E., Neto, C. A. A., Godoy, M. C. B., Souza, C. A., Mançano, A. D., Souza, A. S., Escuissato, D. L., a, B. H., et al. (2015) · Lung · doi:10.1007/s00408-015-9750-6 · Cited by 50
The Tuberous Sclerosis Complex Regulates Trafficking of Glucose Transporters and Glucose Uptake
Jiang, X., Kenerson, H. L., Aicher, L. D., Miyaoka, R. S., Eary, J. F., Bissler, J. J., & Yeung, R. S. W. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070958 · Cited by 50
Time to onset of cannabidiol treatment effect and resolution of adverse events in tuberous sclerosis complex: Post hoc analysis of randomized controlled phase 3 trial GWPCARE6
Wu, J. Y., Cock, H. R., Devinsky, O., Joshi, C., Miller, I., Roberts, C. M., Sánchez-Carpintero, R., Checketts, D., & Sahebkar, F. (2022) · Epilepsia · doi:10.1111/epi.17199 · Cited by 51
Increased Levels of Anxiety-related Behaviors in a Tsc2 Dominant Negative Transgenic Mouse Model of Tuberous Sclerosis
Ehninger, D., & Silva, A. J. (2010) · Behavior Genetics · doi:10.1007/s10519-010-9398-1 · Cited by 51
Distinct clinical characteristics of Tuberous Sclerosis Complex patients with no mutation identified
Camposano, S. E., Greenberg, E., Kwiatkowski, D. J., & Thiele, E. A. (2008) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2008.00496.x · Cited by 49
Assessing the effectiveness of rapamycin on angiomyolipoma in tuberous sclerosis: a two years trial
Cabrera-López, C., Martí, T., Catalá, V., Torres, F., Mateu, S., Ballarín, J., & Torrá, R. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-87 · Cited by 49
Mammalian target of rapamycin (mTOR): a central regulator of male fertility?
Jesus, T. T., Oliveira, P. F., Sousa, M., Cheng, C. Y., & Alves, M. G. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2017.1279120 · Cited by 50
Predictors of Drug-Resistant Epilepsy in Tuberous Sclerosis Complex
Jeong, A., Nakagawa, J. A., & Wong, M. L. (2017) · Journal of Child Neurology · doi:10.1177/0883073817737446 · Cited by 49
Fatty Foci in the Myocardium in Patients with Tuberous Sclerosis Complex: Common Finding at CT
Adriaensen, M. E. A. P. M., Schaefer‐Prokop, C. M., Duyndam, D., Zonnenberg, B. A., & Prokop, M. (2009) · Radiology · doi:10.1148/radiol.2533082118 · Cited by 49
Tuberous Sclerosis Complex as Disease Model for Investigating mTOR-Related Gliopathy During Epileptogenesis
Zimmer, T. S., Broekaart, D. W. M., Gruber, V.-E., van Vliet, E. A., Mühlebner, A., & Aronica, E. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.01028 · Cited by 48
Kidney damage due to tuberous sclerosis complex: Management recommendations
Rouvière, O., Nivet, H., Grenier, N., Laurent Zini, A., & Lechevallier, É. (2013) · Diagnostic and Interventional Imaging · doi:10.1016/j.diii.2013.01.003 · Cited by 48
Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex
Sun, F., Zhang, C., Chen, X., Wei, Y., Li, S., Liu, S., Zang, Z., He, J., Guo, W., & Yang, H. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0546-2 · Cited by 49
Clinical and Genetic Findings in Children with Neurofibromatosis Type 1, Legius Syndrome, and Other Related Neurocutaneous Disorders
Giugliano, T., Santoro, C., Torella, A., Blanco, F. D. V., Grandone, A., Onore, M. E., Melone, M. A. B., Straccia, G., Melis, D., Piccolo, V., et al. (2019) · Genes · doi:10.3390/genes10080580 · Cited by 51
In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor
Gao, L., Yue, M. M., Davis, J., Hyjek, E., & Schuger, L. A. (2014) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-014-1559-9 · Cited by 48
Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model
Rauktys, A., Lee, N. Y., Lee, L., & Dabora, S. L. (2008) · BMC Dermatology · doi:10.1186/1471-5945-8-1 · Cited by 48
Rheb GTPase Controls Apoptosis by Regulating Interaction of FKBP38 with Bcl-2 and Bcl-XL
Ma, D., Bai, X., Zou, H., Lai, Y., & Jiang, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.092353 · Cited by 48
Reduced Juvenile Long-Term Depression in Tuberous Sclerosis Complex Is Mitigated in Adults by Compensatory Recruitment of mGluR5 and Erk Signaling
Potter, W. B., Basu, T., O’Riordan, K. J., Kirchner, A., Rutecki, P. A., Bürger, C., & Roopra, A. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001627 · Cited by 46
The diagnosis and treatment of subependymal giant cell astrocytoma combined with tuberous sclerosis
Jiang, T., Jia, G., Ma, Z., Luo, S., & Zhang, Y. (2010) · Child s Nervous System · doi:10.1007/s00381-010-1159-1 · Cited by 48
MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?
Nadim, W. D., Simion, V., Bénédetti, H., Pichon, C., Baril, P., & Morisset‐Lopez, S. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160709001441 · Cited by 46
Fetal cardiac rhabdomyomas treated with maternal sirolimus
Pluym, I. D., Sklansky, M., Wu, J. Y., Afshar, Y., Holliman, K., DeVore, G. R., Walden, A., Platt, L. D., & Krakow, D. (2019) · Prenatal Diagnosis · doi:10.1002/pd.5613 · Cited by 49
Retinal Abnormalities Characteristic of Inherited Renal Disease
Savige, J., Ratnaike, S., & Colville, D. J. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010090965 · Cited by 47
Mtor As A Potential Treatment Target For Epilepsy
Wong, M. (2012) · Future Neurology · doi:10.2217/fnl.12.45 · Cited by 46
Deletion of Tuberous Sclerosis 1 in Somatic Cells of the Murine Reproductive Tract Causes Female Infertility
Tanaka, Y., Park, J. H., Tanwar, P. S., Kaneko-Tarui, T., Mittal, S., Lee, H., & Teixeira, J. M. (2011) · Endocrinology · doi:10.1210/en.2011-1191 · Cited by 46
The Molecular Biology of Renal Cell Carcinoma
O’Keefe, S. J., Nathanson, K. L., & Rathmell, W. K. (2013) · Seminars in Oncology · doi:10.1053/j.seminoncol.2013.05.006 · Cited by 48
Self-citation
Increased expression of matrix metalloproteinase 9 in cortical lesions from patients with focal cortical dysplasia type IIb and tuberous sclerosis complex
Li, S., Yu, S., Zhang, C., Shu, H., Liu, S., An, N., Yang, M., Yin, Q., & Yang, H. (2012) · Brain Research · doi:10.1016/j.brainres.2012.03.009 · Cited by 48
The Tsc/Rheb signaling pathway controls basic amino acid uptake via the Cat1 permease in fission yeast
Aspuria, P.-J. P., & Tamanoi, F. (2008) · Molecular Genetics and Genomics · doi:10.1007/s00438-008-0320-y · Cited by 46
Brain-expressed X-linked 2 Is Pivotal for Hyperactive Mechanistic Target of Rapamycin (mTOR)-mediated Tumorigenesis
Hu, Z., Wang, Y., Huang, F., Chen, R., Li, C., Wang, F., Goto, J., Kwiatkowski, D. J., Wdzieczak‐Bakala, J., Tu, P., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.665208 · Cited by 46
mTOR-Related Cell-Clearing Systems in Epileptic Seizures, an Update
Limanaqi, F., Biagioni, F., Busceti, C. L., Fabrizi, C., Frati, A., & Fornai, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051642 · Cited by 48
Diffusion Tensor Imaging of Commissural and Projection White Matter in Tuberous Sclerosis Complex and Correlation with Tuber Load
Simão, G. N., Raybaud, C., Chuang, S. H., Go, C., Snead, O. C., & Widjaja, E. (2010) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2033 · Cited by 45
Behavioural and EEG effects of chronic rapamycin treatment in a mouse model of Tuberous Sclerosis Complex
Cambiaghi, M., Cursi, M., Magri, L., Castoldi, V., Comı, G., Minicucci, F., Galli, R., & Leocani, L. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.003 · Cited by 46
Equivalent Benefit of Rapamycin and a Potent mTOR ATP-Competitive Inhibitor, MLN0128 (INK128), in a Mouse Model of Tuberous Sclerosis
Guo, Y., & Kwiatkowski, D. J. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0605 · Cited by 45
The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytoma
Bissler, J. J., Franz, D. N., Frost, M., Белоусова, Е. Д., Bebin, E. M., Sparagana, S. P., Berkowitz, N. C., Ridolfi, A., & Kingswood, J. C. (2017) · Pediatric Nephrology · doi:10.1007/s00467-017-3806-1 · Cited by 45
Effects of antiepileptic drugs in a new TSC/mTOR‐dependent epilepsy mouse model
Koene, L. M. C., van Grondelle, S. E., Onori, M. P., Wallaard, I., Kooijman, N. H. R. M., van Oort, A., Schreiber, J., & Elgersma, Y. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50829 · Cited by 45
Peripheral Serum Exosomes Isolated from Patients with Acute Myocardial Infarction Promote Endothelial Cell Angiogenesis via the miR-126-3p/TSC1/mTORC1/HIF-1α Pathway
Duan, S., Wang, C., Xu, X., Zhang, X., Su, G., Li, Y., Fu, S., Sun, P., & Tian, J. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s338937 · Cited by 45
Low glycemic index treatment for epilepsy in tuberous sclerosis complex
Larson, A. M., Pfeifer, H. H., & Thiele, E. A. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.10.021 · Cited by 45
Inherited Cancer Syndromes in Children and Young Adults
D'Orazio, J. A. (2010) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3181ced34c · Cited by 45
The Central Role of mTORC1 in Amino Acid Sensing
Yue, S., Li, G., He, S., & Li, T. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-4403 · Cited by 45
A Novel Topical Rapamycin Cream for the Treatment of Facial Angiofibromas in Tuberous Sclerosis Complex
Wheless, J. W., & Almoazen, H. (2013) · Journal of Child Neurology · doi:10.1177/0883073813488664 · Cited by 44
Comparison of three rapamycin dosing schedules in A/J Tsc2+/- mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors
Woodrum, C., Nobil, A. M., & Dabora, S. L. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-14 · Cited by 44
PI3K activation in neural stem cells drives tumorigenesis which can be ameliorated by targeting the cAMP response element binding protein
Daniel, P. M., Filiz, G., Brown, D. V., Christie, M., Waring, P., Zhang, Y., Haynes, J. M., Pouton, C. W., Flanagan, D. J., Vincan, E., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy068 · Cited by 42
Tuberous sclerosis complex: From molecular biology to novel therapeutic approaches
Switon, K., Kotulska, K., Janusz, A., Zmorzyńska, J., & Jaworski, J. (2016) · IUBMB Life · doi:10.1002/iub.1579 · Cited by 44
The research landscape of tuberous sclerosis complex–associated neuropsychiatric disorders (TAND)—a comprehensive scoping review
Vanclooster, S., Bissell, S., van Eeghen, A. M., Chambers, N. J., Waele, L. D., Byars, A. W., Capal, J. K., Cukier, S., Davis, P. E., Flinn, J., et al. (2022) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-022-09423-3 · Cited by 43
Cerebellar Development and Autism Spectrum Disorder in Tuberous Sclerosis Complex
Sundberg, M., & Şahin, M. (2015) · Journal of Child Neurology · doi:10.1177/0883073815600870 · Cited by 45
Tuberous Sclerosis Complex Suppression in Cerebellar Development and Medulloblastoma: Separate Regulation of Mammalian Target of Rapamycin Activity and p27Kip1 Localization
Bhatia, B., Northcott, P. A., Hambardzumyan, D., Govindarajan, B., Brat, D. J., Arbiser, J. L., Holland, E. C., Taylor, M. D., & Kenney, A. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1299 · Cited by 42
Unrestrained Mammalian Target of Rapamycin Complexes 1 and 2 Increase Expression of Phosphatase and Tensin Homolog Deleted on Chromosome 10 to Regulate Phosphorylation of Akt Kinase
Das, F., Ghosh‐Choudhury, N., Dey, N., Mandal, C. C., Mahimainathan, L., Kasinath, B. S., Abboud, H. E., & Choudhury, G. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.246397 · Cited by 44
The neural crest lineage as a driver of disease heterogeneity in Tuberous Sclerosis Complex and Lymphangioleiomyomatosis
Delaney, S. P., Julian, L. M., & Stanford, W. L. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00069 · Cited by 40
Mammalian Target of Rapamycin Complex 1 (mTORC1) Enhances Bortezomib-induced Death in Tuberous Sclerosis Complex (TSC)-null Cells by a c-MYC-dependent Induction of the Unfolded Protein Response
Babcock, J. T., Nguyen, H., He, Y., Hendricks, J. W., Wek, R. C., & Quilliam, L. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.431056 · Cited by 43
Rapamycin has a beneficial effect on controlling epilepsy in children with tuberous sclerosis complex: results of 7 children from a cohort of 86
Canpolat, M., Per, H., Gumus, H., Yıkılmaz, A., Unal, E., Patiroglu, T., Çinar, L., Kurtsoy, A., & Kumandaş, S. (2014) · Child's Nervous System · doi:10.1007/s00381-013-2185-6 · Cited by 43
Activation of Rheb, but not of mTORC1, impairs spine synapse morphogenesis in tuberous sclerosis complex
Yasuda, S., Sugiura, H., Katsurabayashi, S., Shimada, T., Tanaka, H., Takasaki, K., Iwasaki, K., Kobayashi, T., Hino, O., & Yamagata, K. (2014) · Scientific Reports · doi:10.1038/srep05155 · Cited by 43
Cystic lung disease is not uncommon in men with tuberous sclerosis complex
Ryu, J. H., Sykes, A.-M. G., Lee, A. S., & Burger, C. D. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2012.07.007 · Cited by 42
Lateralized interictal epileptiform discharges during rapid eye movement sleep correlate with epileptogenic hemisphere in children with intractable epilepsy secondary to tuberous sclerosis complex
Ochi, A., Hung, R., Weiss, S. K., Widjaja, E., To, T., Nawa, Y., Shima, T., Go, C., Akiyama, T., Donner, E. J., et al. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03198.x · Cited by 42
Tubers and tumors: rapamycin therapy for benign and malignant tumors
Plas, D. R., & Thomas, G. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.12.013 · Cited by 42
The Pathophysiology of the Lungs in Tuberous Sclerosis
Harris, J. O., Bl, W., & Swenson, E. W. (1969) · American Review of Respiratory Disease · doi:10.1164/arrd.1969.100.3.379 · Cited by 42
Genetic animal models of malformations of cortical development and epilepsy
Wong, M., & Roper, S. N. (2015) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2015.04.007 · Cited by 40
Diffusion Tensor Imaging and Related Techniques In Tuberous Sclerosis Complex: Review and Future Directions
Peters, J. M., Taquet, M., Prohl, A. K., Scherrer, B., van Eeghen, A. M., Prabhu, S. P., Şahin, M., & Warfield, S. K. (2013) · Future Neurology · doi:10.2217/fnl.13.37 · Cited by 43
Non-Clear Cell Renal Cancer: Disease-Based Management and Opportunities for Targeted Therapeutic Approaches
Linehan, W. M., Srinivasan, R., & Garcia, J. A. (2013) · Seminars in Oncology · doi:10.1053/j.seminoncol.2013.05.009 · Cited by 42
Enhanced Epidermal Growth Factor, Hepatocyte Growth Factor, and Vascular Endothelial Growth Factor Expression in Tuberous Sclerosis Complex
Parker, W. E., Orlova, K. A., Heuer, G. G., Baybis, M., Aronica, E., Frost, M., Wong, M., & Crino, P. B. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.11.031 · Cited by 43
Self-citation
Systemic disease manifestations associated with epilepsy in tuberous sclerosis complex
Jeong, A., & Wong, M. L. (2016) · Epilepsia · doi:10.1111/epi.13467 · Cited by 41

Authors: Crino, P. B., Nathanson, K. L., & Henske, E. P.
Affiliations: University of Pennsylvania Health System (US)
University of Pennsylvania (US)
Fox Chase Cancer Center (US)
ORCID: Crino, Peter B.
Nathanson, Katherine L.
Henske, Elizabeth Petri
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2006-09-28
Volume: 355
Issue: 13
Pages: 1345-1356
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra055323
OpenAlex: W2383259826
Cited by: 1,793
References: 98
Citations by year: 2026: 39 · 2025: 61 · 2024: 73 · 2023: 61 · 2022: 79 · 2021: 96 · 2020: 94 · 2019: 67 · 2018: 95 · 2017: 101 · 2016: 102 · 2015: 109 · 2014: 119 · 2013: 146 · 2012: 129
FWCI: 7.94
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (HL60746, R01HL060746)
National Institute of Diabetes and Digestive and Kidney Diseases (DK-51052)
National Institute of Neurological Disorders and Stroke (NS045021, R01NS045021)
Topics: Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
Health Sciences › Medicine › Dermatology › Genetic and rare skin diseases.
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords: tuberous sclerosis complex, TSC1, hamartin, TSC2, tuberin, autosomal dominant disorder, pathogenesis, disease management, multisystem disease
MeSH terms: Tuberous Sclerosis Complex 1 Protein, Tuberous Sclerosis Complex 2 Protein, Estrogens, Female, Humans, Genetic Linkage, Male, Mutation, Protein Kinases, Tuberous Sclerosis, Signal Transduction, Tumor Suppressor Proteins, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Tuberous Sclerosis Complex

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks